<http://schema.org/description>
"Implementing an aggregate spend program in a global marketplace.  Treating industry codes, laws, and regulations without considering the broader global transparency landscape, is not an option if companies intend to develop smart transparency approaches and supporting models that more efficiently and effectively address what is required of them. Many of the regulations and requirements imposed on pharmaceutical and life sciences companies have commonalities that create opportunities for businesses to incorporate process efficiencies and economies of scale when developing their transparency strategies."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.pwc.com/us/aggregatespend>